Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis.

He YZ, Hu X, Chi XS, Zhang YC, Deng XB, Wei MT, Wang ZQ, Zhou YH.

Tumour Biol. 2014 Jan;35(1):615-21. doi: 10.1007/s13277-013-1085-4. Epub 2013 Aug 17.

PMID:
23955800
2.

135G/C polymorphism in the RAD51 gene and acute myeloid leukemia risk: a meta-analysis.

Wu L, Long ZG, Dai ZS.

Genet Mol Res. 2016 Apr 4;15(2). doi: 10.4238/gmr.15027383.

3.

Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis.

Li C, Liu Y, Hu Z, Zhou Y.

Leuk Lymphoma. 2014 Jun;55(6):1309-19. doi: 10.3109/10428194.2013.835404. Epub 2013 Oct 24.

PMID:
23978154
4.

Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls.

Zhang BB, Wang DG, Xuan C, Sun GL, Deng KF.

Fam Cancer. 2014 Dec;13(4):515-26. doi: 10.1007/s10689-014-9729-0.

PMID:
24859942
5.

Association between the RAD51 135 G>C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls.

Wang W, Li JL, He XF, Li AP, Cai YL, Xu N, Sun SM, Wu BY.

PLoS One. 2013 Sep 9;8(9):e75153. doi: 10.1371/journal.pone.0075153. eCollection 2013.

6.

RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis.

Cheng D, Shi H, Zhang K, Yi L, Zhen G.

Diagn Pathol. 2014 Jan 23;9:18. doi: 10.1186/1746-1596-9-18.

7.

RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects.

Wang Z, Dong H, Fu Y, Ding H.

Breast Cancer Res Treat. 2010 Dec;124(3):765-9. doi: 10.1007/s10549-010-0885-0. Epub 2010 Apr 16.

PMID:
20396943
8.

RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies.

Gao LB, Pan XM, Li LJ, Liang WB, Zhu Y, Zhang LS, Wei YG, Tang M, Zhang L.

Breast Cancer Res Treat. 2011 Feb;125(3):827-35. doi: 10.1007/s10549-010-0995-8. Epub 2010 Jul 17.

PMID:
20640595
9.

The effect of RAD51 135 G>C and XRCC2 G>A (rs3218536) polymorphisms on ovarian cancer risk among Caucasians: a meta-analysis.

Shi S, Qin L, Tian M, Xie M, Li X, Qi C, Yi X.

Tumour Biol. 2014 Jun;35(6):5797-804. doi: 10.1007/s13277-014-1769-4. Epub 2014 Mar 6.

PMID:
24599673
10.

RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies.

Yu KD, Yang C, Fan L, Chen AX, Shao ZM.

Breast Cancer Res Treat. 2011 Apr;126(2):365-71. doi: 10.1007/s10549-010-0937-5. Epub 2010 May 12.

PMID:
20461453
11.

RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis.

Zhou GW, Hu J, Peng XD, Li Q.

Breast Cancer Res Treat. 2011 Jan;125(2):529-35. doi: 10.1007/s10549-010-1031-8. Epub 2010 Jul 11.

PMID:
20623332
12.
13.

135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.

Smolarz B, Samulak D, Michalska M, Góralczyk B, Szyłło K, Lewy J, Sporny S, Kokołaszwili G, Burzyński M, Romanowicz-Makowska H.

Pol J Pathol. 2011 Sep;62(3):157-62.

14.

Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.

Tian X, Dai S, Sun J, Jiang S, Jiang Y.

Sci Rep. 2016 Apr 7;6:24097. doi: 10.1038/srep24097.

15.

Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.

Feng YQ, Li YU, Xiao WD, Wang GX, Li YO.

Genet Mol Res. 2015 Oct 28;14(4):13391-402. doi: 10.4238/2015.October.28.1.

16.

TIRAP C539T polymorphism contributes to tuberculosis susceptibility: evidence from a meta-analysis.

Liu Q, Li W, Li D, Feng Y, Tao C.

Infect Genet Evol. 2014 Oct;27:32-9. doi: 10.1016/j.meegid.2014.06.025. Epub 2014 Jul 5.

PMID:
25003251
17.

RAD51 Gene 135G/C polymorphism and ovarian cancer risk: a meta-analysis.

Hu X, Sun S.

Int J Clin Exp Med. 2015 Dec 15;8(12):22365-70. eCollection 2015.

18.

Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies.

Zhao M, Chen P, Dong Y, Zhu X, Zhang X.

PLoS One. 2014 Jan 27;9(1):e87259. doi: 10.1371/journal.pone.0087259. eCollection 2014.

19.

Association of XRCC3 Thr241Met polymorphism and leukemia risk: evidence from a meta-analysis.

Yan Y, Liang H, Li T, Guo S, Li M, Qin X, Li S.

Leuk Lymphoma. 2014 Sep;55(9):2130-4. doi: 10.3109/10428194.2013.853303. Epub 2014 Feb 4.

PMID:
24304418
20.

Correlations between MDM2 gene SNP309 polymorphism and susceptibility to leukemia.

Ou WB.

Med Sci Monit. 2015 Jan 16;21:213-8. doi: 10.12659/MSM.892919.

Supplemental Content

Support Center